BiotechTube
SweetBio

SweetBio

Memphis, United States· Est.
sweetbio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.0M

Overview

SweetBio is a commercial-stage medical device company focused on advanced wound care through its proprietary biomaterial platform combining collagen and Manuka honey. Its two main products, VERIS (daily dressing) and APIS (weekly skin substitute), are designed for chronic and acute wounds, are reimbursed by Medicare, and are supported by clinical evidence demonstrating faster closure times. The company, led by its co-founders, targets the large and growing market for chronic wound management with a differentiated, evidence-based approach.

Wound CareDermatology

Technology Platform

Proprietary biomaterial platform combining collagen and Manuka honey engineered to modulate the wound microenvironment, providing antimicrobial, anti-inflammatory, and pro-regenerative effects.

Funding History

2
Total raised:$2.0M
Seed$1.8M
Grant$250K

Opportunities

The large and growing chronic wound market, driven by diabetes and aging demographics, presents a significant opportunity.
Established Medicare reimbursement and contracts with VA/DOD provide a clear pathway for adoption and revenue.
The compelling clinical data showing faster closure times can drive market share gains against older standards of care.

Risk Factors

Intense competition from large, well-funded medical device companies with broader portfolios poses a market penetration challenge.
Dependency on favorable and stable reimbursement codes (HCPCS A6021, A2010) from Medicare and private insurers is a persistent financial risk.
As a small private company, scaling commercial operations and manufacturing efficiently with limited resources is a key execution risk.

Competitive Landscape

SweetBio competes in the crowded advanced wound care market against major players like 3M, Smith & Nephew, and Integra LifeSciences, who offer a wide range of collagen, antimicrobial, and advanced dressings. Its direct differentiation lies in its specific combination of collagen and integrated Manuka honey, positioned as a cleaner, more convenient, and evidence-based alternative to both plain collagen dressings and topical Manuka honey products.

More companies in Drug Delivery & Formulation →More companies in United States →